RV
RVL Pharmaceuticals plc
RVLPQ · OTC
$0.00 +0.00% (+$0.00)
Market Cap $1.11K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.00x
P/B 0.00x
P/E N/A
Growth
0 /100
Declining Rev. growth 40.83%
Book val. growth 23.63%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 80.98%
Net margin 103.96%
FCF margin 77.56%
Quality
7 /100
Poor ROIC 41.26%
ROA 40.22%
Asset turnover 0.39x
Debt
64 /100
Moderate Debt/Equity 1.13x
Current ratio 2.89x
Net debt/EBITDA -0.36x
Stability
22 /100
Unstable Beta 8.91x
Rev. volatility 144.80%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o RVLPQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Brian A. Markison
Employees
125
Headquarters
Bridgewater
Nadchodzące wydarzenia
13 LIS
Earnings
Upcoming earnings report